RT Journal Article
SR Electronic
T1 Transmission Dynamics of COVID-19 in Malaysia Prior to the Movement Control Order
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.07.20021188
DO 10.1101/2020.02.07.20021188
A1 Labadin, J
A1 Hong, B.H
YR 2020
UL http://medrxiv.org/content/early/2020/04/30/2020.02.07.20021188.abstract
AB This paper focuses on the formulation of a deterministic COVID-19 transmission model by considering the exposed and recovered populations with immunity. The scenario of the simulation is depicted based on the patient zero in Malaysia. The transmission model is found to be able to predict the next confirmed case given a single case is introduced in a fully susceptible population. The mathematical model is developed based on the SEIR model which has susceptible, exposed, infectious and recovered populations. The system of equations which were obtained were solved numerically and the simulation results were analyzed. The analysis includes the impact of the disease if no control is taken.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors thank Universiti Malaysia Sarawak for the support rendered for postgraduate studies, the Sarawak Multimedia Authority for the research grant numbered RG/F08/SMA/05/2018 entitled Decision Analytics for Disease Alerts. Our heartfelt thanks also go to Malaysia Ministry of Health, Malaysia Department of Statistics for publishing the required research data.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data obtained are publicly available from trusted sources